Build a Type 2 Diabetes Risk Screening App with Ovok in 30 Minutes

A ten-step Expo and React Native implementation guide for FINDRISC, FHIR questionnaires, TeleBGM Gen1 BLE, and blood-glucose Observations.

Build a small patient app that stores a validated FINDRISC assessment as a FHIR QuestionnaireResponse and saves TeleBGM Gen1 BLE readings as FHIR-backed blood-glucose Observations. It uses the current @ovok/native and @ovok/core APIs.

The “30 minutes” is a guided implementation target for an engineer with an Expo environment and an approved questionnaire resource already available. Native builds, Console setup, BLE pairing, and clinical content review will take longer.

What you will build

  • Patient registration and sign-in for an Ovok sandbox project.
  • An approved FINDRISC Questionnaire rendered with QuestionnaireForm.
  • A locally calculated score using the questionnaire’s reviewed version and an explicit scoring map. Ovok does not currently provide a FINDRISC scoring operation.
  • Optional standard FHIR questionnaire extraction only when the approved Questionnaire is configured for it.
  • TeleBGM Gen1 BLE discovery and a normalized blood-glucose measurement saved with ovok.measurements.save().
  • Separate assessment and glucose histories, localized through Ovok CMS.

Clinical and content boundary

FINDRISC is a risk-screening instrument, not a diagnosis. A blood-glucose reading is a measurement; this tutorial does not interpret it as diabetes, combine it with FINDRISC into a new score, or give treatment advice. The published Finnish Diabetes Association guidance says its risk result is not a diagnosis and does not replace a health professional’s assessment. See its use instructions and sources and the original Diabetes Risk Score paper.

The guide does not reproduce FINDRISC question text, answer labels, or a translated instrument. Before deploying, obtain the exact questionnaire and any required permissions, attribution, and validated translations from an authorized source. Have the responsible clinical owner confirm the instrument version, answer order, scoring map, and result wording. The app must fail closed if the installed Questionnaire version is not the reviewed version.

Before you start

  • Node.js, Expo tooling, Xcode and/or Android Studio.
  • A physical iOS or Android device for Bluetooth tests. Expo Go cannot run the BLE native module.
  • Access to the Ovok Console and a sandbox project.
  • The approved FHIR Questionnaire for the classic eight-item FINDRISC version, already published to the sandbox project. The newer nine-question Finnish risk-test flow is a different instrument and must not be substituted into the eight-item score mapping.
  • A TeleBGM Gen1 BLE meter and compatible test strips. Use synthetic patient data in the sandbox.

The current Sandbox CapabilityStatement advertises standard CRUD/search for Questionnaire, QuestionnaireResponse, and Observation, plus the Questionnaire/$populate and QuestionnaireResponse/$extract operations. Confirm against the live FHIR R4 CapabilityStatement for the project you use.

Build the app

StepPageResult
1Create the React Native appExpo Router project with native build and BLE dependencies
2Create and configure the Ovok projectLeast-privilege sandbox patient workflow
3Configure localisationi18next reads published UI copy from Ovok CMS
4Choose the glucose deviceTeleBGM Gen1 BLE allowlist uses IntegratedDevices.BGM
5Add the FINDRISC QuestionnaireVersion-checked questionnaire and tested score mapping
6Initialise Ovok, auth, and BluetoothOne client, authenticated Patient routes, one BLE runtime
7Build the screening homePatient can complete and save the questionnaire
8Connect TeleBGM and save readingsPair device and save glucose readings as Observations
9Build results and historyDistinct FINDRISC and glucose history views
10Settings, localisation, and validationCMS-backed UI, language preference, and sandbox journey checks

Canonical references

Last updated on

On this page